BRADFORD GALE: Open Payments
NPI 1932126976 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 69 payments from 18 companies in 2025. Trend: 2023 $1,047 · 2024 $903 · 2025 $1,079
Food & beverage: $1,079
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $308 |
| Amgen Inc. | 11 | $208 |
| Axsome Therapeutics, Inc. | 5 | $102 |
| Tris Pharma Inc | 3 | $52 |
| Novo Nordisk Inc | 3 | $49 |
| PFIZER INC. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Astellas Pharma US Inc | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $30 |
Products named: VRAYLAR, REPATHA, UBRELVY, QULIPTA, JARDIANCE, Dyanavel XR, Auvelity, Ozempic.
Industry payments across UT — which companies pay providers there.
